Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Rev. méd. Chile ; 118(12): 1362-6, dic. 1990. tab
Artigo em Espanhol | LILACS | ID: lil-96886

RESUMO

We studied the effect of flutamide, a peripheral androgenic blocking agent, 500 mg daily for days in 7 non ovalating patients with hirsutism. Totañl and HDL cholestero, triglycerides, testosterone and dehydroepiandrosterone sulphate (S-DHEA) plasma levels were measured in patients and in 6 non ovulating control women of similar age and weight. Only basal HDL levels were lower in patients than in controls (40.2 ñ 1.6 vs 51.4 weight Only basal HDL levels were lower in patients than in controls (40.2 ñ 1.6 vs 51.4 ñ 3.3mg/dl, p < 0.01). A decrease in S-DHEA levels was observed after flutamide in patients with hirsutism (3.2 ñ 0.4 to 2.1 ñ 0.4, p < 0.01) which may be attributed to the lowering of cortisol clearance induced by the drug. total testosterone and plasma lipoproteins reamined stable. Thus, peripheral androgenic blockade does not modify the decreased levels of HDL cholesterol in non ovulating patients with hirsutim


Assuntos
Adolescente , Adulto , Humanos , Feminino , Flutamida/uso terapêutico , Hirsutismo/tratamento farmacológico , Anovulação/tratamento farmacológico , Grupos Controle , Androgênios , Lipoproteínas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...